(주)팜젠사이언스 · KOSPI: 004720 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩166.8B | ₩171.3B | ₩173.1B |
| Operating income | ₩9.1B | ₩10.6B | ₩6.0B |
| Net income | ₩6.1B | ₩2.8B | −₩116.6B |
| Total assets | ₩342.0B | ₩363.5B | ₩195.4B |
| Total liabilities | ₩109.0B | ₩114.0B | ₩49.1B |
| Total equity | ₩233.0B | ₩249.4B | ₩146.3B |
| Share capital | ₩9.0B | ₩9.1B | ₩11.0B |
Separate statements · FY2025 operating margin 3.5% · liabilities to equity 34% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 60 (current) | 삼정회계법인 | Unqualified |
| Term 59 (prior) | 태일회계법인 (구, 회계법인 세일원) | Unqualified |
| Term 59 (prior) | 태일회계법인 (구, 회계법인 세일원) | Unqualified |
| Term 58 (two years prior) | 회계법인 세일원 | Unqualified |
| Date | Largest shareholder (Korean) | Stake | Cause (Korean) |
|---|---|---|---|
| 2020년 06월 03일 | 에이치디투자조합 | — | 주식양수도계약 |
| 2025년 12월 11일 | 한의상 | — | 33CB 전환청구권 행사 |
| Date | Filing | Original |
|---|---|---|
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-06-01 | Corporate governance report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-05-15 | Amended: Annual report (2025.12) | DART |
| 2026-05-12 | Officer / major shareholder ownership report | DART |
| 2026-05-12 | Large shareholding (5%+) report | DART |
| 2026-05-12 | Change in shareholdings of largest shareholder | DART |
| 2026-05-12 | Conversion / warrant / exchange rights exercised | DART |
| 2026-03-31 | Independent director appointment / dismissal / resignation | DART |
| 2026-03-31 | Change of CEO (notice) | DART |
| 2026-03-31 | Annual general meeting results | DART |
| 2026-03-23 | Amended: Proxy solicitation reference document | DART |
| 2026-03-23 | Amended: Notice of shareholders meeting | DART |
| 2026-03-23 | Annual report (2025.12) | DART |
| 2026-03-23 | Audit report submitted | DART |
| 2026-03-12 | Proxy solicitation reference document | DART |
| 2026-03-12 | Notice of shareholders meeting | DART |
| 2026-03-12 | Resolution to convene shareholders meeting | DART |
| 2026-03-11 | Adjustment of conversion / exercise / exchange price (notice) | DART |
| 2026-02-09 | Revenue or profit structure changed materially | DART |
Showing the 20 most recent of 31 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.